Bioventus (BVS) Cash from Operations (2020 - 2026)

Bioventus' Cash from Operations history runs 7 years deep, the most recent figure standing at 8934000.0 for Q1 2026.

• Quarterly Cash from Operations rose 146.22% year-over-year to 8934000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 102938000.0 (up 304.17% YoY) and the FY2025 annual result came in at 74673000.0, up 92.48% from the prior year.
• Cash from Operations was 8934000.0 for Q1 2026 at Bioventus, down from 37968000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 37968000.0 in Q4 2025 and bottomed at 21019000.0 in Q2 2022.
• A 5-year average of 7306411.76 and a median of 8934000.0 in 2026 frame the typical range for Cash from Operations.
• Peak annual rise in Cash from Operations reached 267.3% in 2023, while the deepest fall reached 6735.44% in 2023.
• Bioventus' Cash from Operations stood at 4385000.0 in 2022, then jumped by 136.58% to 10374000.0 in 2023, then surged by 86.25% to 19322000.0 in 2024, then surged by 96.5% to 37968000.0 in 2025, then sank by 76.47% to 8934000.0 in 2026.
• Business Quant data shows BVS's Cash from Operations at 8934000.0 in Q1 2026, 37968000.0 in Q4 2025, and 30098000.0 in Q3 2025.